Pharmacology at the start of a new millennium. Larger assortment and individual drug dosing are coming
Fredholm, B.B.; Sjöqvist, F.
Lakartidningen 98(6): 534-539
2001
ISSN/ISBN: 0023-7205 PMID: 11475239 Document Number: 538844
Document emailed within 1 workday
Related Documents
Foster, H.W. 1997: Women's health care for the coming millennium Journal of the Florida Medical Association 84(6): 358-363Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Bach, K.F.; Jørgensen, A. 2013: Simplification of procedures for clinical drug trials in the EU is coming up Ugeskrift for Laeger 175(46): 2778-2781
Phillips, D.R.; White, R.J.; Trist, H.; Cullinane, C.; Dean, D.; Crothers, D.M. 1990: New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNA Anti-Cancer Drug Design 5(1): 21-29
Kahan, B.D.; Gibbons-Stubber, S.; Tejpal, N.; Chou, T.C. 1992: Prospects for synergistic immunosuppressive drug therapy in the coming decade Transplantation Proceedings 24(4): 1263-1265
Jain, N. 2019: Optimizing drug dosing for the treatment of chronic lymphocytic leukemia Clinical Advances in Hematology and Oncology: H&o 17(6): 330-331
Zhou, Q.; Yu, L.-s.; Zeng, S. 2017: Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters Yao Xue Xue Bao 52(1): 1-7
Borcherding, S.M.; Stevens, R.; Nicholas, R.A.; Corley, C.R.; Self, T. 1996: Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions Journal of Family Practice 42(1): 69-78
Ruzicka, T.; Assmann, T.; Homey, B. 1999: Tacrolimus: the drug for the turn of the millennium? Archives of Dermatology 135(5): 574-580
Zimarino, M.; De Caterina, R. 2004: Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit Journal of Cardiovascular Pharmacology 43(3): 325-332
Parge, M.; Endter, B.; Moldenhauer, J.; Lauter, T. 2003: A difficult start in life... Drug withdrawal in newborn infants from the nursing viewpoint Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 22(11): 480-483
Conroy, S. 1998: Unlicensed and off label drug use for paediatric patients. Optimal dosing schedules with gentamicin are needed for premature neonates Bmj 317(7152): 204-205
Beverley, E.V. 1976: An assortment of fitness programs for the unconditioned retiree Geriatrics 31(2): 122 126 130-1
Sawicki, B. 1979: Assortment and speed of distribution of drugs in public pharmacies Folia Medica Cracoviensia 21(1): 193-198
Johnson, G.; Wu, T.T. 1998: Possible assortment of a1 and a2 region gene segments in human MHC class I molecules Genetics 149(2): 1063-1067
Akashi, A.; Chiba, T.; Suzuki, I.; Hashimoto, H. 1978: Pharmacology of budralazine, a new antihypertensive drug Archives Internationales de Pharmacodynamie et de Therapie 235(1): 134-146
Sonntag, A.C.; Stenger, V.G.; Vogh, B.P.; Maren, T.H. 1972: The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey Journal of Pharmacology and Experimental Therapeutics 182(1): 34-47
Allen, T.; Parker, M. 2011: The "other diseases" of the Millennium Development Goals: rhetoric and reality of free drug distribution to cure the poor's parasites Third World Quarterly 32(1): 91-117